This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a […]
Biosimilar Naming: Distinguishable or Disingenuous? Read Post »
[slideshare id=61425574&doc=whendodrugpatentsexpire-160427163211] When do drug patents expire, and when can generic drugs launch? An overview of patents, non-patent regulatory exclusivities,
When do Drug Patents Expire, and When Can Generic Drugs Launch? Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharmaceutical companies have the most “New Dosage Form” drugs? Read Post »
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharma companies have the most ‘New Dosage Form’ exclusivities? Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…
Bioentrepreneurship education programmes in the United States Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant posi…
Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.”
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Understanding ‘science and the public’
Go to paperABSTRACT: Public acceptance of the products of biotechnology is an important issue for the industry. T…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores…